Hubei Minkang Pharmaceutical LTD (HBMK) financial statements (2021 and earlier)

Company profile

Business Address 55 UBI AVE, #03-01
MINTWELL BUILDING, 408864
State of Incorp. NV
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments6,2346,073
Cash and cash equivalents6,2346,073
Receivables9561,616
Inventory, net of allowances, customer advances and progress billings3,9853,221
Inventory3,9853,221
Advances on inventory purchases576484
Deposits current assets589 
Prepaid expense and other current assets39
Other current assets1,575
Other undisclosed current assets6851,765
Total current assets:14,59913,199
Noncurrent Assets
Property, plant and equipment4,7404,848
Other undisclosed noncurrent assets2,2762,445
Total noncurrent assets:7,0167,293
TOTAL ASSETS:21,61520,491
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2,2783,404
Accounts payable2,2783,228
Taxes payable 176
Debt3,2723,170
Other liabilities393434
Other undisclosed current liabilities4,2452,530
Total current liabilities:10,1889,538
Noncurrent Liabilities
Total liabilities:10,1889,538
Stockholders' equity
Stockholders' equity attributable to parent11,42710,953
Common stock5252
Additional paid in capital5,8245,824
Accumulated other comprehensive income1,7181,371
Retained earnings3,8333,706
Total stockholders' equity:11,42710,953
TOTAL LIABILITIES AND EQUITY:21,61520,491

Income statement (P&L) ($ in thousands)

12/31/2013
12/31/2012
Revenues14,74313,919
Cost of revenue
(Cost of Goods and Services Sold)
(8,314)(7,163)
Other undisclosed gross profit(139) 
Gross profit:6,2896,756
Operating expenses(6,555)(5,898)
Other undisclosed operating income308167
Operating income:421,024
Nonoperating income (expense)32(70)
Investment income, nonoperating3122
Other nonoperating expense(12)(24)
Interest and debt expense(221)(237)
Other undisclosed income from continuing operations before equity method investments, income taxes221237
Income from continuing operations before income taxes:73955
Income tax benefit546
Net income available to common stockholders, diluted:127961

Comprehensive Income ($ in thousands)

12/31/2013
12/31/2012
Net income:127961
Comprehensive income:127961
Other undisclosed comprehensive income, net of tax, attributable to parent34768
Comprehensive income, net of tax, attributable to parent:4741,030

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: